Form 4 Destination Maternity For: Apr 20 Filed by: Schriver Rodney

April 23, 2019 5:02 PM
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Schriver Rodney

(Last) (First) (Middle)
C/O DESTINATION MATERNITY CORPORATION
232 STRAWBRIDGE DRIVE

(Street)
MOORESTOWN NJ 08057

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Destination Maternity Corp [ DEST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/20/2018 A 20,000 (1) A $ 0 45,000 (2) D
Common Stock 12/04/2018 F 2,085 (3) D $ 3.97 42,915 (4) D
Common Stock 04/20/2019 F 1,933 (5) D $ 2.17 40,982 (6) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 2.65 04/20/2018 A 20,000 (7) 04/20/2028 Common Stock 20,000 $ 0 20,000 D
Explanation of Responses:
1. On April 20, 2018, 20,000 shares of restricted stock were granted to the Reporting Person by the Issuer (the "2018 Restricted Stock Grant"). The restricted stock vests in four (4) equal annual installments beginning on April 20, 2019.
2. Includes the 2018 Restricted Stock Grant and 25,000 shares of restricted stock granted to the Reporting Person on December 4, 2017, which vests in four (4) equal annual installments beginning on December 4, 2018 (the "2017 Restricted Stock Grant").
3. 2,085 shares of common stock of the Issuer ("common stock") were surrendered to the Issuer to pay applicable tax withholdings in connection with the December 4, 2018 vesting of 6,250 shares of restricted stock pursuant to the 2017 Restricted Stock Grant.
4. Includes the 2018 Restricted Stock Grant and 18,750 shares of unvested restricted stock pursuant to the 2017 Restricted Stock Grant.
5. 1,933 shares of common stock were surrendered to the Issuer to pay applicable tax withholdings in connection with the April 20, 2019 vesting of 5,000 shares of restricted stock pursuant to the 2018 Restricted Stock Grant.
6. Includes 15,000 shares of unvested restricted stock pursuant to the 2018 Restricted Stock Grant and 18,750 shares of unvested restricted stock pursuant to the 2017 Restricted Stock Grant.
7. On April 20, 2018, options to purchase 20,000 shares of common stock were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on April 20, 2019.
/s/ Rodney Schriver 04/23/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings